https://www.selleckchem.com/pr....oducts/4-hydroxytamo
To investigate the economic impact of an intracameral mydriatics and anesthesic agent (ICMA), topical mydriatics, and a mydriatic ocular insert in cataract patients. One public hospital in the Netherlands. Prospective cohort study. Resource use data were collected from a healthcare and societal perspective on the day of surgery. Other outcome parameters included pupil size, surgeon satisfaction, postoperative pain, and Catquest-9SF scores. Mean costs per patient were OV0556; 506 in the ICMA group (n=122)
כמו
תגובה
לַחֲלוֹק
